Latest News about EXEL
Recent news which mentions EXEL
The Top Healthcare Stocks to Buy With $100
August 30, 2023
From Motley Fool
Exelixis' Lead Cancer Treatment Delivers Another Surprise, Though Analyst Finds Commercial Opportunity In Pancreatic Neuroendocrine Modest
August 24, 2023
From Benzinga
2 No-Brainer Biotech Stocks to Buy Right Now
August 24, 2023
From Motley Fool
These Are the ONLY 3 Biotech Stocks to Consider in August 2023
August 21, 2023
From InvestorPlace
Third Time Lucky: Exelixis' Cabozantinib Combo Therapy Aces Pivotal Study In Prostate Cancer Patients
August 21, 2023
From Benzinga
3 Biotech Stocks You’ll Regret Not Buying Soon
August 08, 2023
From InvestorPlace
Benzinga's Top Ratings Upgrades, Downgrades For August 8, 2023
August 08, 2023
From Benzinga
From InvestorPlace
2 Biotech Growth Stocks I'd Buy Right Now
July 27, 2023
From Motley Fool
From InvestorPlace
3 No-Brainer Stocks to Buy With $200 Right Now
June 21, 2023
From Motley Fool
From Motley Fool
2 Under-the-Radar Biotech Stocks to Buy in 2023
May 24, 2023
From Motley Fool
From Motley Fool
From Motley Fool
From Motley Fool
From Motley Fool
2 Under-the-Radar Biotech Stocks to Buy in 2023
April 05, 2023
From Motley Fool
From Benzinga
Farallon Capital Might Undertake Proxy Fight Against Exelixis, Nominates Three Directors
April 05, 2023
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
